Comparison · NCT02866175-deaths
Edoxaban Regimen vs Vitamin K Antagonist Regimen: deaths from any cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Edoxaban Regimen vs Vitamin K Antagonist Regimen: deaths from any cause. Trial comparisons, record NCT02866175-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02866175-deaths
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0617 | 0.0465 | 0.0813 | wilson | |
| Risk in group 2 | 0.05 | 0.0365 | 0.0682 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0117 | -0.012 | 0.0355 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.23 | 0.81 | 1.88 | log | |
| Odds ratio, group 1 over group 2 | 1.25 | 0.8 | 1.95 | log | |
| Number needed to harm, for one more death from any cause on Edoxaban Regimen than on Vitamin K Antagonist Regimen | 85.7 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Edoxaban Regimen | Participants who were randomized to Edoxaban 60 mg once-daily or 30 mg once-daily and clopidogrel 75 mg once-daily (or in the presence of a documented clinical need prasugrel \[5 mg or 10 mg once-daily\] or ticagrelor \[90 mg twice-daily\] may be used). | 46 | 746 | EG000 |
| Group 2 | Vitamin K Antagonist Regimen | Participants who were randomized to VKA in combination with clopidogrel 75 mg once-daily (or in the presence of a documented clinical need prasugrel \[5 mg or 10 mg once-daily\] or ticagrelor \[90 mg twice-daily\] may be used) and aspirin (100 mg once-daily, for a minimum of 1 month and up to 12 months duration). | 37 | 740 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, all-cause mortality
- Time frame
- Adverse events were collected from Day 1 to 30 days after last dose, up to 2 years, 4 months.
Source ClinicalTrials.gov
Trial
- Title
- Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- NCT number
- NCT02866175
- Phases
- PHASE3
- Conditions
- Atrial Fibrillation
- Interventions
- Edoxaban, Clopidogrel, Prasugrel, Ticagrelor, Vitamin K antagonist
- Lead sponsor
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
- Results first posted
- 2020-05-06
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02866175?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02866175-deaths